Fenofibrate and its active metabolite, fenofibric acid, are primarily excreted by the kidneys. It is nondialysable, and studies in patients with moderate chronic kidney disease (GFR <50 ml/min/1. ...

Adjunct to diet: in severe hypertriglyceridemia; and to reduce elevated total-C, LDL-C, ApoB, and TG, and to increase HDL-C in primary hyperlipidemia and mixed dyslipidemia. Take with food ...

Fenofibrate is used along with a proper diet to help lower "bad" cholesterol and fats (such as LDL, triglycerides) and raise "good" cholesterol (HDL) in the blood. Ezetimibe is used along with a ...

Confused about cholesterol levels Learn the difference between high triglycerides and bad cholesterol exploring their impact ...

Analysts have set 12-month price targets for ANI Pharmaceuticals, revealing an average target of $79.8, a high estimate of ...

The Diabetes and Combined Lipid Therapy Regimen (DIACOR) study 62 found that combination therapy with simvastatin plus fenofibrate had a superior ability than monotherapy with either drug to ...

Aug. 14, 2024 — More than a quarter of Australians over the age of 50 take cholesterol-lowering drugs to prevent heart disease and strokes, but our bodies also need cholesterol to survive. Now ...

原发性硬化性胆管炎(Primary Sclerosing Cholangitis，PSC)是一种慢性胆汁淤积性肝病，其特征是胆管炎症和纤维化导致的胆管狭窄，最终可进展为肝硬化、肝衰竭。

He is a listed applicant on a patent application in relation to the use of fenofibrate for treatment of diabetic retinopathy. He holds no shares, stocks or options in any pharmaceutical company.